Ganesh Dnyandeo Gunjal

Ganesh Dnyandeo Gunjal

Active Director Director DIN 08462662
DIN 08462662 First appointment May 2019 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganesh Dnyandeo Gunjal

Data last updated:

Ganesh Dnyandeo Gunjal is a Director at Denken Pharmaceuticals Private Limited (since 2019). The company operates in Food And Beverages.

DIN 08462662
Primary Designation Director
Industry Food And Beverages
First Appointment 24 May 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 May 20192019Active

Board colleagues of Ganesh Dnyandeo Gunjal

NameDINCompanyDesignation
Amey Mahadeo Godse08462661Denken Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denken Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ganesh Dnyandeo Gunjal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Dnyandeo Gunjal

Ganesh Dnyandeo Gunjal currently holds 1 directorship: Denken Pharmaceuticals Private Limited (Director, since 24 May 2019).

Ganesh Dnyandeo Gunjal was first appointed on 24 May 2019 as Director at Denken Pharmaceuticals Private Limited.

The current boards of Ganesh Dnyandeo Gunjal's companies include Amey Mahadeo Godse (Denken Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available